Do You Suffer from Pain Caused by Neuropathy?
Subjects suffering from high blood sugar have reported neuropathy pain relief minutes after D'OXYVA® (deoxyhemoglobin vasodilator) was administered and long-term blood sugar level improvements in just a few weeks.
Rapid and gentle transdermal (over-the-skin) delivery with the D'OXYVA light-weight and hand-held device has recorded improving the blood (micro) circulation or perfusion index (PI) by up to 23%* in all participants. (Measured lasting results at 5–60 minutes and up to 4 hours after single 5–minute D'OXYVA delivery on skin surface, no reduction in PI levels.)*Average results rounded for display, based on number of enrolled subjects in each clinical study with D'OXYVA.
Request Clinical Paper >
Taking D'OXYVA daily, users have reported a number of quality of life benefits beyond significantly reducing risks of chronic conditions, including but not limited to:
Click here and learn more about how taking D'OXYVA® just a few times a week could start your new life today!
What it does
In short, based on current leading neurology, immunology, microvascular, and cellular oxygenation science, D'OXYVA is leading the field by quickly targeting to:
Significantly lower the risk of diabetes and cardiovascular complications
Provide complete healing of difficult wounds together with major pain relief and improved quality of life:
How it works
It is non-electrical, handheld, painless, fast, and easy to use with no adverse side effects, according to years of user feedback and the results of past clinical trials with D'OXYVA.
It is an affordable, stand alone and adjunct application locally and all over the body. Taking D'OXYVA is easy; hold it against your skin surface for 5 minutes total, like comfortably inserting your thumb or anywhere you are hurt.
D'OXYVA has recorded instant, outsized, and sustained improvements of the autonomic nervous system (ANS) in the brain leading to major tissue perfusion, blood circulation in macro-, and microcirculation enhancement in controlled human clinical trials (Phase I to III). These benefits result in significant improvements of essential physiological processes and clinical outcomes.
D'OXYVA delivers the highest possible concentration of CO2 and has been clinically studied to significantly increase lasting blood flow volume in the microcirculatory system.
In addition, increased microcirculation with CO2 is widely known to increase the perfusion of oxygen.
Shop All Products >
- Taking D'OXYVA
- User Reviews